Power Law company profile

CG Oncology

Biotech & Life Sciences · Irvine, United States · Founded 2010 · IPO 2024 Unicorn

Focused on developing bladder cancer therapeutics

Valuation

$5.14B

Market cap · May/2026

Revenue

$4.0M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

18 investors on CG Oncology's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Ally Bridge Group

Series B+ 17 investors entered at this stage

ORI Capital

RA Capital Management

Camford Capital

Asian Healthcare Fund

Malin Corporation

Perseverance Capital Management

WI Harper Group

Longitude Capital

Acorn Bioventures

TCGX

BVF Partners

Decheng Capital

Avidity Partners

Kissei Pharmaceutical

Foresite Capital

Janus Henderson Investors

Sirona Capital

Global footprint

Where CG Oncology has talent and traffic

Workforce by country

🇺🇸 United States · Irvine HQ

Book a demo for the full country breakdown

Web traffic by country

11K monthly visits
across markets

🇺🇸 United States60.9%

🇮🇳 India19.1%

🇬🇧 United Kingdom11.8%

🇨🇦 Canada6.4%

🇵🇭 Philippines2.7%

Top 5 markets shown

Patent intelligence

$9M patent portfolio · 3 active families

Estimated portfolio value

$9M

0.18% of market cap · 14.4× smaller than top peer Deciphera Pharmaceuticals ($133M)

3 active patent families

Where CG Oncology innovates Cancer researchCell biologyOncolytic virusCell specificOncology

Where CG Oncology concentrates vs peers

Each axis is a top-10 topic across CG Oncology and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about CG Oncology

An AI-synthesized read of the highest-engagement posts about CG Oncology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CG Oncology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles